Login / Signup

[Acetylsalicylic acid in primary and secondary prevention of atherosclerotic cardiovascular disease].

O Sh OynotkinovaSimon T MatskeplishviliO M MaslennikovaA I PavlovA G Poberezhskaya
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The article is devoted to an urgent problem - primary and secondary prevention of atherosclerotic cardiovascular diseases. Modern approaches to management tactics depending on age and the appointment of antiplatelet therapy with acetylsalicylic acid in low doses from 75 to 150 mg/day are presented. At the same time, the relatively high effectiveness of the use of ASA for primary prevention in men 40-69 years old without an increased risk of bleeding from the gastrointestinal tract is shown. Low doses of ASA provide little benefit in reducing the risk of CVD in people 40 years and older, when there is no history of CVD, but at the same time they are at increased risk of CVD.
Keyphrases